Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Airi Han"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Articles
Expressional Difference of RHEB, HDAC1, and WEE1 Proteins in the Stromal Tumors of the Breast and Their Significance in Tumorigenesis
Minseob Eom, Airi Han, Mi Jeong Lee, Kwang Hwa Park
Korean J Pathol. 2012;46(4):324-330.   Published online August 23, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.4.324
  • 7,150 View
  • 42 Download
  • 7 Crossref
AbstractAbstract PDF
Background

Fibroadenoma (FA) and phyllodes tumor (PT) are stromal tumors of breast and are histologically similar. There are no established differences in tumorigenesis and oncogene expression among them. Ras homolog enriched in brain (RHEB) plays an important role in cell growth and cell-cycle control, histone deacetylase 1 (HDAC1) is an important factor in breast tumor progression and prognosis, and WEE1 homolog (WEE1) functions as a tumor suppressor. No studies on the expressional differences of these proteins in FA and PT have been reported to date.

Methods

The expression of these proteins in FA, PT, and normal breast was compared. We used 102 cases of FA and 25 cases of benign PT.

Results

In epithelial cells, the expression of RHEB, HDAC1, and WEE1 was lowest in PT, higher in FA, and most enhanced in normal breast. In addition, the expression of RHEB and HDAC1 was higher in the stromal cells of PT than in FA and normal breast.

Conclusions

Both epithelial and stromal cells of FA and PT express these proteins, which indicates that epithelial cells play an important role in the development of stromal tumors. In addition, the expressional differences of these proteins may be associated with the tumorigenesis of breast stromal tumors.

Citations

Citations to this article as recorded by  
  • Gut microbiota-derived 3-phenylpropionic acid promotes intestinal epithelial barrier function via AhR signaling
    Jun Hu, Jianwei Chen, Xiaojian Xu, Qiliang Hou, Jing Ren, Xianghua Yan
    Microbiome.2023;[Epub]     CrossRef
  • Genome-scale meta-analysis of breast cancer datasets identifies promising targets for drug development
    Reem Altaf, Humaira Nadeem, Mustafeez Mujtaba Babar, Umair Ilyas, Syed Aun Muhammad
    Journal of Biological Research-Thessaloniki.2021;[Epub]     CrossRef
  • Wee1 Kinase: A Potential Target to Overcome Tumor Resistance to Therapy
    Francesca Esposito, Raffaella Giuffrida, Gabriele Raciti, Caterina Puglisi, Stefano Forte
    International Journal of Molecular Sciences.2021; 22(19): 10689.     CrossRef
  • MiR-503 enhances the radiosensitivity of laryngeal carcinoma cells via the inhibition of WEE1
    Huimin Ma, Rong Lian, Zhiyan Wu, Xiao Li, Wenfa Yu, Yun Shang, Xixia Guo
    Tumor Biology.2017; 39(10): 101042831770622.     CrossRef
  • Rheb phosphorylation is involved in p38-regulated/activated protein kinase-mediated tumor suppression in liver cancer
    MIN ZHENG, SHENGBING ZANG, LINNA XIE, XUETING FANG, YU ZHANG, XIAOJIE MA, JINGFENG LIU, DEXIN LIN, AIMIN HUANG
    Oncology Letters.2015; 10(3): 1655.     CrossRef
  • Expression of CDK1Tyr15, pCDK1Thr161, Cyclin B1 (Total) and pCyclin B1Ser126 in Vulvar Squamous Cell Carcinoma and Their Relations with Clinicopatological Features and Prognosis
    Zhihui Wang, Ana Slipicevic, Mette Førsund, Claes G. Trope, Jahn M. Nesland, Ruth Holm, Xin-Yuan Guan
    PLOS ONE.2015; 10(4): e0121398.     CrossRef
  • High expression of wee1 is associated with malignancy in vulvar squamous cell carcinoma patients
    Gry Irene Magnussen, Ellen Hellesylt, Jahn M Nesland, Claes G Trope, Vivi Ann Flørenes, Ruth Holm
    BMC Cancer.2013;[Epub]     CrossRef
HDAC1 Expression in Invasive Ductal Carcinoma of the Breast and Its Value as a Good Prognostic Factor
Minseob Eom, Sung Soo Oh, Sayamaa Lkhagvadorj, Airi Han, Kwang Hwa Park
Korean J Pathol. 2012;46(4):311-317.   Published online August 23, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.4.311
  • 6,511 View
  • 51 Download
  • 6 Crossref
AbstractAbstract PDF
Background

Histone deacetylase 1 (HDAC1) is associated with the expression and function of estrogen receptors and the proliferation of tumor cells, and has been considered a very important factor in breast tumor progression and prognosis. Several studies have reported an association between HDAC1 expression and poorer prognosis in cancers including breast cancer, with a few exceptions. However, because of the dearth of studies on HDAC1 expression in breast cancer, its significance for breast cancer prognosis has not been well defined. Therefore, we examined HDAC1 expression in invasive ductal carcinoma (IDC), the most common breast cancer, and investigated its potential prognostic significance.

Methods

We used 203 IDC tissue samples. Immunohistochemical stains for HDAC1 and real-time polymerase chain reaction for HDAC1 mRNA were performed and the results were compared to generally well-established prognostic factors in breast cancer and patient survival rates.

Results

HDAC1 expression was significantly reduced in proportion to higher histologic grade, higher nuclear pleomorphism score, and higher mitotic counts, and with lower estrogen receptor expression. Furthermore, it was significantly associated with the survival rate.

Conclusions

HDAC1 expression is a good prognostic indicator in IDC.

Citations

Citations to this article as recorded by  
  • SNP rs4971059 predisposes to breast carcinogenesis and chemoresistance via TRIM46‐mediated HDAC1 degradation
    Zihan Zhang, Xiaoping Liu, Lei Li, Yang Yang, Jianguo Yang, Yue Wang, Jiajing Wu, Xiaodi Wu, Lin Shan, Fei Pei, Jianying Liu, Shu Wang, Wei Li, Luyang Sun, Jing Liang, Yongfeng Shang
    The EMBO Journal.2021;[Epub]     CrossRef
  • The Impact of Androgen Receptor and Histone Deacetylase 1 Expression on the Prognosis of Ductal Carcinoma In Situ
    Choong Man Lee, Il Yong Chung, Yangsoon Park, Keong Won Yun, Hwi Gyeong Jo, Hye Jin Park, Hee Jin Lee, Sae Byul Lee, Hee Jeong Kim, Beom Seok Ko, Jong Won Lee, Byung Ho Son, Sei Hyun Ahn, Jisun Kim
    Journal of Breast Cancer.2020; 23(6): 610.     CrossRef
  • Prognostic and clinical significance of histone deacetylase 1 expression in breast cancer: A meta-analysis
    Weiqiang Qiao, Heyang Liu, Ruidong Liu, Qipeng Liu, Ting Zhang, Wanying Guo, Peng Li, Miao Deng
    Clinica Chimica Acta.2018; 483: 209.     CrossRef
  • HDAC1 triggers the proliferation and migration of breast cancer cells via upregulation of interleukin-8
    Zhaohui Tang, Sijuan Ding, Honglin Huang, Pengfei Luo, Bohua Qing, Siyuan Zhang, Ruoting Tang
    Biological Chemistry.2017; 398(12): 1347.     CrossRef
  • Identification of novel histone deacetylase 1 inhibitors by combined pharmacophore modeling, 3D-QSAR analysis, in silico screening and Density Functional Theory (DFT) approaches
    Sanjay K. Choubey, Richard Mariadasse, Santhosh Rajendran, Jeyakanthan Jeyaraman
    Journal of Molecular Structure.2016; 1125: 391.     CrossRef
  • The potential of histone deacetylase inhibitors in breast cancer therapy
    Namita Chatterjee, Martin Tenniswood
    Breast Cancer Management.2015; 4(2): 85.     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine